Mandate

Vinge has represented Acast in connection with EUR 25 million financing from EIB

August 30, 2019 Banking and Finance

The Swedish leading podcast company Acast has signed a EUR 25 million financing agreement with the European Investment Bank (EIB).  

The EIB financing is supported by the European Fund for Strategic Investments (EFSI), the main pillar of the Investment Plan for Europe (known as the ”Juncker Plan”), the purpose of which is to provide alternative sources of financing to innovative companies. The financing agreement provides a ”quasi-equity” financing without resulting in EIB owning any shares in Acast. 

Acast was founded in 2014, has its headquarters in Stockholm and services available in ten different countries. 

Vinge’s team included Sofia Törnroth Nyberg and Albert Wållgren (Banking & Finance), and Johan Larsson and Vilhelm Rondahl (M&A).
 

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026